Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Safety and Efficacy of Low‐Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders
Denise K. Patten, Bob G. Schultz, Daniel J. Berlau
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2018) Vol. 38, Iss. 3, pp. 382-389
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Nociplastic pain: towards an understanding of prevalent pain conditions
Mary‐Ann Fitzcharles, Steven P. Cohen, Daniel J. Clauw, et al.
The Lancet (2021) Vol. 397, Iss. 10289, pp. 2098-2110
Closed Access | Times Cited: 749
Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
Karlo Toljan, Bruce Vrooman
Medical Sciences (2018) Vol. 6, Iss. 4, pp. 82-82
Open Access | Times Cited: 120
Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities
Mark D. Namba, Jonna M. Leyrer‐Jackson, Erin K. Nagy, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 56
Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study
Brendan O’Kelly, Louise Vidal, Tina McHugh, et al.
Brain Behavior & Immunity - Health (2022) Vol. 24, pp. 100485-100485
Open Access | Times Cited: 56
Fibromyalgia Pathophysiology
Michael Gyorfi, Adam Rupp, Alaa Abd‐Elsayed
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3070-3070
Open Access | Times Cited: 45
Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19
Anar Isman, Andy Nyquist, Bailey Strecker, et al.
Brain Behavior & Immunity - Health (2024) Vol. 36, pp. 100733-100733
Open Access | Times Cited: 14
Guideline No. 445: Management of Chronic Pelvic Pain
Catherine Allaire, Paul J. Yong, Krisztina Bajzak, et al.
Journal of Obstetrics and Gynaecology Canada (2024) Vol. 46, Iss. 1, pp. 102283-102283
Closed Access | Times Cited: 14
A Literature Review: The Mechanisms and Treatment of Neuropathic Pain—A Brief Discussion
Renira Rugnath, Casey Orzechowicz, Clayton R. Newell, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 204-204
Open Access | Times Cited: 10
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy
Zijian Li, Yue You, Noreen Griffin, et al.
International Immunopharmacology (2018) Vol. 61, pp. 178-184
Closed Access | Times Cited: 70
Advances in the Understanding and Management of Chronic Pain in Multiple Sclerosis: a Comprehensive Review
Ivan Urits, Leena Adamian, Jacob Fiocchi, et al.
Current Pain and Headache Reports (2019) Vol. 23, Iss. 8
Closed Access | Times Cited: 70
Pain management in hidradenitis suppurativa and a proposed treatment algorithm
Kevin T. Savage, Vinita Singh, Zarine S. Patel, et al.
Journal of the American Academy of Dermatology (2020) Vol. 85, Iss. 1, pp. 187-199
Open Access | Times Cited: 55
Alcohol and Pain: A Translational Review of Preclinical and Clinical Findings to Inform Future Treatment Strategies
Scott Edwards, Leandro F. Vendruscolo, Nicholas W. Gilpin, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 44, Iss. 2, pp. 368-383
Open Access | Times Cited: 54
TLR4 biased small molecule modulators
Cong Lin, Hongshuang Wang, Miyuan Zhang, et al.
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107918-107918
Closed Access | Times Cited: 44
Therapeutic Approaches to the Neurologic Manifestations of COVID-19
Edith L. Graham, Igor J. Koralnik, Eric M. Liotta
Neurotherapeutics (2022) Vol. 19, Iss. 5, pp. 1435-1466
Open Access | Times Cited: 33
Effective Doses of Low-Dose Naltrexone for Chronic Pain – An Observational Study
Norman J. Marcus, Lexi Robbins, Aya Araki, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 1273-1284
Open Access | Times Cited: 6
Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia
Hiten Naik, Erin Cooke, Travis Boulter, et al.
BMJ Open (2024) Vol. 14, Iss. 5, pp. e085272-e085272
Open Access | Times Cited: 6
The uses of naltrexone in dermatologic conditions
Brigette Lee, Dirk M. Elston
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 6, pp. 1746-1752
Closed Access | Times Cited: 52
Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment
Rachel E. Gicquelais, Amy M. Bohnert, Laura Thomas, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 47
Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis
Monica Bolton, Alexander Hodkinson, Shivani Boda, et al.
BMC Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 45
Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
Michael J. Lucido, Boadie W. Dunlop
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 161-161
Open Access
Pyridostigmine and low-dose naltrexone for ME/CFS: study protocol for the Life Improvement Trial (LIFT), a randomized, double-blind, placebo-controlled clinical trial
Danielle Meadows, Johanna Squires, J B Dibble, et al.
(2025)
Closed Access
Integrative Medicine in Women
Anne Kennard, Erin F. Gillespie, Reagan McKendree
Primary Care Clinics in Office Practice (2025)
Closed Access
Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes
Diana Trofimovitch, Steven J. Baumrucker
American Journal of Hospice and Palliative Medicine® (2019) Vol. 36, Iss. 10, pp. 907-912
Closed Access | Times Cited: 42
A Link Between Inflammatory Mechanisms and Fibromyalgia
Ashika Bains, Samuel Kohrman, Diana Punko, et al.
Advances in experimental medicine and biology (2023), pp. 357-378
Closed Access | Times Cited: 11
Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches
Dingpei Long
Biomedicines (2024) Vol. 12, Iss. 3, pp. 689-689
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top